[Experience of Elcitonin treatment in metastatic bony pain of urological tumors]

Hinyokika Kiyo. 1988 Jul;34(7):1273-7.
[Article in Japanese]

Abstract

Fourteen cases of urogenital tumors (9 prostatic carcinomas, 4 renal cell carcinomas and 1 bladder carcinoma) which had bone metastases were treated with eel-calcitonin, Elcitonin injections for relief of bony pain. Forty mgs. of Elcitonin was injected intramuscularly, 2 to 3 times a week, to out-patients. Forty to 80 mgs. of Elcitonin was injected intramuscularly, daily to hospitalized patients. Relief of the pain was obtained in 71.4% of all patients (71.4% of out-patients and 71.4% of hospitalized patients) and especially in 88.9% of prostatic carcinoma patients. Hypercalcemia was seen in only one patient of renal cell carcinoma. It is considered that Elcitonin treatment is useful for relief of bony pain in the patients with bone metastases, with or without hypercalcemia.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bone Neoplasms / physiopathology
  • Bone Neoplasms / secondary*
  • Calcitonin / analogs & derivatives*
  • Calcitonin / therapeutic use
  • Carcinoma, Renal Cell / pathology*
  • Carcinoma, Renal Cell / physiopathology
  • Humans
  • Kidney Neoplasms / pathology*
  • Kidney Neoplasms / physiopathology
  • Male
  • Middle Aged
  • Pain Measurement
  • Pain, Intractable / drug therapy*
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / physiopathology

Substances

  • Calcitonin
  • elcatonin